Clinical Trial Update: The Efficacy of Influenza Vaccine in Reducing Cardiovascular Events in Patients With Coronary Artery Diseases [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/Phase 3 clinical trial evaluating whether influenza vaccination reduces cardiovascular events in patients with coronary artery disease, myoc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Myocardial Infarction
• Stable Angina

Drugs mentioned

• Influenza vaccine (influenza vaccine)

Snippet

Sponsor: Shahid Beheshti University of Medical Sciences | Conditions: Coronary Artery Diseases, Myocardial Infarction | Phase 2, Phase 3 | Status: COMPLETED